Babson Diagnostics inks $31m Series B

Babson Diagnostics, a medical technology company, has raised $31 million in Series B funding.

Babson Diagnostics, a medical technology company, has raised $31 million in Series B funding. Emerald Development Managers led the round with participation from Siemens Healthineers, Prism Ventures, and Lago Consulting Group.

Source: Press Release